In fact, current investigations have indicated p53 is mutated in 12% of luminal type A, 29% of luminal type B, 72% of HER2-enriched (HER2+), and 80% of basal-like breast tumors [6,11,12]. Here, ERBB2 is linked to breast neoplasm.